Enhancer I predominance in hepatitis B virus gene expression.
about
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional SequestrationHepatitis B virus molecular biology and pathogenesisModulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1αCRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusMicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 proteinPGC-1alpha controls hepatitis B virus through nutritional signalsThe inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Molecular functions and biological roles of hepatitis B virus x protein.HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection.High-level expression and large-scale preparation of soluble HBx antigen from Escherichia coli.CRTC2 enhances HBV transcription and replication by inducing PGC1α expression.Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression.Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells.Polypyrimidine tract binding protein (PTB) associates with intronic and exonic domains to squelch nuclear export of unspliced RNA.Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies.Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity.Bioluminescence imaging of hepatitis B virus enhancer and promoter activities in mice.Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha.Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA.GCN5 acetyltransferase inhibits PGC1α-induced hepatitis B virus biosynthesis.Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity.The epsilon motif of hepatitis B virus RNA exhibits a potassium-dependent ribonucleolytic activity.MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.Collective repression of the hepatitis B virus enhancer II by human TR4 and TR2 orphan receptors.Silencing Retinoid X Receptor Alpha Expression Enhances Early-stage Hepatitis B Virus Infection In Cell Cultures.Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA.
P2860
Q23035986-54CBCD75-4B31-4401-86D2-71E5BC6732E7Q28818406-D261CCAA-91EB-4883-92EC-18B27AAEAC06Q33698542-0FC0388F-54CD-4FE6-A960-ACF60363D855Q34478938-371E4908-F009-4FEB-828A-AD06B3A3F6B4Q34683454-6326DFF1-E71E-4334-B48C-29E87D9E5185Q35127598-4254FD09-7E35-4810-9929-E6B0F273AD4AQ35191793-D9AE5F8A-81DF-4CEF-94DE-117BE7D1C638Q35343911-0345644B-FE3C-4CEA-B2CF-BAD1D007BDB7Q36597687-A2DB1927-69FA-439D-952E-12BE36D1D427Q37045394-B7D015F4-5954-4F33-A4CD-CA364DF40F18Q37282726-1E43F63F-E7E2-430A-8189-C0B4547A1F52Q37434367-4A4894C9-F35B-44F2-9532-8C10FAA66E02Q37613444-149780AA-0AB0-4E56-995B-DB3BFDB4A347Q37833669-6E963F92-B898-49C2-8146-D61F0BFB7B24Q38643087-018663BB-C2BF-4C2C-9001-17A844A354EEQ38891568-1B718456-7294-4AB8-803C-068A0A225EB2Q39075069-3778D29D-4F95-4E84-9270-73F2E568306CQ39272853-8CC0C282-B90D-40A6-87F3-92F8470DCD63Q39439256-F898C465-6EF9-4E12-BDF8-D3A912DD5569Q39934941-B6340F3E-89D7-43CE-9C6F-512C4A48EE2FQ39943758-1C227ECA-4037-4B1E-BA22-D42F04195E8AQ40179034-FAB623C0-78D8-45D6-A161-0DFFCDD25936Q42279224-31C6AFC8-6E81-43C2-A612-55EE3CBA7286Q43057268-D1068806-C6B5-4F77-9A96-35542EA47548Q45330254-5F141ECA-C204-4603-ACEE-2F0AB7DB868EQ45366262-CD5AE801-C8EB-49B6-BD4F-010D976D5CABQ45401705-5538E7EA-FFFB-4DFA-ACAD-3044EBB5A64BQ50043353-BE621107-389C-48E4-B72D-AF8A2D4FB747Q55380360-24C71096-03D5-4E84-9181-44B6D8F93026
P2860
Enhancer I predominance in hepatitis B virus gene expression.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Enhancer I predominance in hepatitis B virus gene expression.
@ast
Enhancer I predominance in hepatitis B virus gene expression.
@en
Enhancer I predominance in hepatitis B virus gene expression.
@nl
type
label
Enhancer I predominance in hepatitis B virus gene expression.
@ast
Enhancer I predominance in hepatitis B virus gene expression.
@en
Enhancer I predominance in hepatitis B virus gene expression.
@nl
prefLabel
Enhancer I predominance in hepatitis B virus gene expression.
@ast
Enhancer I predominance in hepatitis B virus gene expression.
@en
Enhancer I predominance in hepatitis B virus gene expression.
@nl
P2860
P1476
Enhancer I predominance in hepatitis B virus gene expression.
@en
P2093
Gilad Doitsh
Yosef Shaul
P2860
P304
P356
10.1128/MCB.24.4.1799-1808.2004
P407
P577
2004-02-01T00:00:00Z